Board of Directors


MARC is governed by its Board of Directors, which consists of up to 15 members.  The Board provides leadership and oversight of:  the strategic direction of the organization; performance of management staff in meeting ESRD network contract requirements and deliverables; activities and recommendations of the Network Council, Medical Review Board and Patient Advisory Committee; the financial operation of the organization; and corporate compliance.
 
The membership of the Board of Directors includes representatives of a variety of health care settings and disciplines relevant to the ESRD population, which may include hospitals, dialysis centers, nursing homes, home health, hospice, dialysis patients and other consumers, physicians, and other clinical and administrative professionals.  Members are selected to be broadly representative of the network service area.
 
Directors are appointed for three-year terms and generally may serve no more than two consecutive terms.  Terms are staggered so that approximately one-third of the directors are appointed each year.  Directors are appointed by MARC’s corporate member, Quality Insights Holdings, Inc. (QIH). Appointments are made at the first QIH Board of Directors meeting of the calendar year, or otherwise as vacancies arise.  MARC directors are not compensated for Board service other than reimbursement of travel-related expenses.


Members


John Wiesendanger, MHA Chair
West Virginia Medical Institute/Quality Insights
Charleston, West Virginia
Appointed: Ex Officio

Louis Diamond, MB, ChB, FACP Vice Chair
Quality Healthcare Consultants
Rockville, Maryland
Appointed: January 2014, 3-year term

Derrick Latos, MD Secretary/Treasurer
Nephrology Associates, Inc.
Wheeling, West Virginia
Appointed: January 2014, 2-year term

Paul Conway
Medicare Beneficiary
Falls Church, Virginia
Appointed: January 2014, 3-year term

Debbie Cote, MSN, RN, CNN
University of Virginia Health System
Charlottesville, Virginia
Appointed: January 2014, 2-year term

Malene Davis
Capital Caring
Arlington, Virginia
Appointed: January 2015, 3-year term

Andrew D. Howard, MD, FACP
Metropolitan Nephology Associates
Alexandria, Virginia
Appointed: July 2014, 2-year term

Patrick Kelly
West Virginia Healthcare Association
Charleston, West Virginia
Appointed: January 2014, 2-year term

Richard Knight, MBA
Medicare Beneficiary
New Carrollton, Maryland
Appointed: January 2015, 3-year term

Paul Light, MD
University of Maryland Hospital, Nephrology Division
Baltimore, Maryland
Appointed: January 2014, 2-year term

Frank Maddux, MD
Specialty Care Services Group
Danville, Virginia
Appointed: January 2014, 3-year term

Jack Moore, MD
Washington Hospital Center, Section of Nephrology
Washington, DC
Appointed: January 2014, 2-year term

Jeffrey Perlmutter, MD MRB Chair 
Nephrology Associates of Montgomery County
Rockville, Maryland
Appointed: January 2014, 3-year term

Leslie Pionke
Inova Transplant Education Center
Annandale, Virginia
Appointed: January 2014, 2-year term

Christopher Simon, MSW
Independent Dialysis Foundation
Frederick, Maryland
Appointed: July 2014, 3-year term
 

Board Committees


The Board of Directors has established an Executive Committee and a Compliance Committee.  The Executive Committee is empowered to act between regular Board meetings consistent with the direction of the full Board.  The Executive Committee may also assist in identifying potential new director candidates.  The Executive Committee is comprised of the officers of the Board (chair, vice chair, and secretary-treasurer) and such other directors as the Board may appoint.

 

The Compliance Committee provides oversight of the corporate ethics and compliance program as it relates to MARC.  It receives regular reports from the corporate compliance officer and is notified of any significant instances of non-compliance with contractual or other legal obligations.  The Compliance Committee consists of the officers of the Board and such other directors as the Board may appoint.  A majority must be independent directors.